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Jersey, Piscataway, New JerseyABSTRACT The efficacy of electroporation is known to vary significantly across a wide variety of biological research and
clinical applications, but as of this writing, a generalized approach to simultaneously improve efficiency and maintain viability
has not been available in the literature. To address that discrepancy, we here outline an approach that is based on the mapping
of the scaling relationships among electroporation-mediated molecular delivery, cellular viability, and electric pulse parameters.
The delivery of Fluorescein-Dextran into 3T3 mouse fibroblast cells was used as a model system. The pulse was rationally split
into two sequential phases: a first precursor for permeabilization, followed by a second one for molecular delivery. Extensive
data in the parameter space of the second pulse strength and duration were collected and analyzed with flow cytometry. The
fluorescence intensity correlated linearly with the second pulse duration, confirming the dominant role of electrophoresis
in delivery. The delivery efficiency exhibited a characteristic sigmoidal dependence on the field strength. An examination of
short-term cell death using 7-Aminoactinomycin D demonstrated a convincing linear correlation with respect to the electrical
energy. Based on these scaling relationships, an optimal field strength becomes identifiable. A model study was also performed,
and the results were compared with the experimental data to elucidate underlying mechanisms. The comparison reveals the
existence of a critical transmembrane potential above which delivery with the second pulse becomes effective. Together, these
efforts establish a general route to enhance the functionality of electroporation.INTRODUCTIONElectroporation-mediated molecular delivery is an effective
means to manipulate cells in biological research and medi-
cal applications (1–5). In this method, cells are exposed
to an applied electric field to transiently permeabilize
the membrane, and facilitate the uptake of biologically
active molecules into the cytoplasm. This physical delivery
method has been applied widely in areas such as drug and
gene delivery, protein insertion, and cancer therapy, among
others (3–9).
Fundamental studies demonstrated that electroporation-
mediated molecular delivery is affected by both membrane
permeabilization and molecular transport into the cyto-
plasm (10–13). The pulsing parameters, cell size, and
conductivity across the cellular membrane regulate the
transmembrane potential that controls the degree of mem-
brane permeabilization (14–24). The target molecules are
transported through the permeabilized membrane into the
cytoplasm, and the process depends on their size and
charge. Molecules with larger size (MW > 4 (25)) such
as DNA rely mainly on electrophoresis and other mem-
brane-DNA interactions, such as endocytosis, to traverse
the cell membrane (1,12,24–27). Simple diffusion and
electrophoresis mechanisms are speculated to control the
transport of smaller molecules such as calcium, propi-
dium iodide, Lucifer yellow, and most drug molecules
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0006-3495/14/02/0801/12 $2.00Extensive research has been performed to improve electro-
poration (5,34–43). Various strategies have been employed,
including the optimization of the electric field parameters
(pulse shape (16,44–46), electric field pulse strength
(37,39,47–49), and duration (25,50)), the electroporation
media (buffer electrical conductivity (18,28,29,31,33,51)),
osmolarity (52–54), and chemical composition (28,55–
57)), and novel chip design (10,39,53,58–61). Of particular
interest to this study is the first approach, namely, the explo-
ration of the pulsing parameter space to enhance molecular
delivery and viability. Earlier studies utilized single pulses
with relatively high field strength (27,62) to perform both
permeabilization and transport (26,42,63). Although an
appreciable delivery can be achieved, a large portion of the
permeabilized cells do not survive the electrical shock
(37,38). To overcome this limitation, more elaborate pulsing
designs have been used, including unipolar and bipolar
pulses (45), alternating-current fields (64), non-square-
wave forms (16), pulse trains (17,25,52,54,63), and a combi-
nation of pulses with high and low field strengths (denoted
by ‘‘HV’’ and ‘‘LV’’, respectively) (27,62,65,66). Notably,
an elaborate series of work by Puc et al. (32) and Pucihar
et al. (67) resulted in the development of an optimization
scheme for the delivery of small molecules and viability us-
ing single pulses, which was later complemented by a study
revealing pulse parameterswith equivalent permeabilization.
Despite the progresses demonstrated by these attempts, the
protocols and the corresponding approaches, due to their
lack of generality, could not be readily translated into a
widely applicable methodology.http://dx.doi.org/10.1016/j.bpj.2013.12.045
802 Sadik et al.The main objective of this work is to identify a possible
route for protocol optimization based on contemporary
understanding of electroporation mechanisms. For this pur-
pose, the combination of HV/LV pulses is attractive. This
approach is based on the idea that permeabilization and
transport can be treated as separate tasks, and can be accom-
plished by HV and LV, respectively. The application of the
HV pulse is in general a necessary condition for membrane
permeabilization, presumably to overcome the critical
threshold of the transmembrane potential (27,66). On the
other hand, once permeabilization is achieved, an LV can
be employed to deliver the molecules effectively while
simultaneously decreasing damage due to field exposure
(27,65,66). This approach has been proven to be effective
by many studies for the delivery of large molecules using
different pulsing parameters such as HV and LV field
strengths, their duration, and the delay between them. For
example, Sukharev et al. (27) showed that extending the
second pulse duration enhanced DNA uptake, which scales
linearly with electrical charge. A series of studies by Andre´
and Mir (1), Andre´ et al. (66), and Bureau et al. (68) demon-
strated the necessity of second pulses in delivering DNA
in vivo. Using a control system for in vivo electroporation,
Cukjati et al. (69) controlled the degree of permeabilization
by adjusting the first pulse of the HV/LV sequence in real-
time, and demonstrated that tissue complexity affected
significantly the delivery efficiency. Kanduser et al. (65)
used various combinations of HV/LV pulses that appre-
ciably enhanced the relative transfection efficiency of
eGFP plasmid vectors. Similar trends were observed by
Stroh et al. (62) when eGFP plasmid vectors and siRNA
were delivered to primary cells and different cell lines.
These studies demonstrated that the use of HV/LV combina-
tion is a promising approach for enhancing delivery. How-
ever, important questions remain:
1. How do the HV/LV pulses quantitatively affect delivery,
and do lower and higher bounds exist for effective deliv-
ery with the LV pulse?
2. How does viability scale with the field strength and dura-
tion of the LV pulse?
3. Is an optimal pulsing scheme identifiable to simulta-
neously enhance delivery and viability?
The answers to these questions will help us establish a
generalized method that is based on scaling relationships
among delivery, viability, and electric pulse parameters.
In this work, we begin to address these questions by
systematically characterizing the scaling behavior of both
delivery and (short-term) cell viability with respect to puls-
ing parameters in combined HV/LV electroporation. We
used 3T3 mouse fibroblasts as a model cell. The applied first
pulse had a relatively strong field strength (100,000 V/m)
and a duration of 0.001 s. Without delay, a second pulse is
applied with field strength and duration varying from
10,000 to 100,000 V/m and 0.01 to 0.1 s, respectively.Biophysical Journal 106(4) 801–812The target molecule for delivery was Fluorescein-Dextran
(FD), a chain polymer with a molecular weight of
~10,000. We chose this molecule due to its nonbinding
nature, and its proximity in size to small RNA, peptides,
and drug molecules (12,25,50,70). Cellular viability was
assayed using 7-Aminoactinomycin D (7-AAD). The data
were collected with high-throughput fluorescence-based
flow cytometry for a statistically significant number of
cells (10,000) to construct a comprehensive mapping of
delivery and viability (37,47,62,70). These results allow us
to analyze the system behavior extensively, from which an
optimization scheme emerges. In addition, we also compare
the experimental results to a whole-cell level transport
model that quantitatively predicted both membrane perme-
ability and FD delivery. The comparison provides mecha-
nism-based interpretations of the experimental data. The
combined efforts establish a general methodology for the
improvement of electroporation as a delivery technique: a
systematic optimization can be pursued if these scaling
relationships become available.MATERIALS AND METHODS
Cell culture
NIH 3T3 mouse fibroblast cells were cultured in Dulbecco’s Modified
Eagle Medium supplemented with Fetal Bovine Serum (10% v/v), Peni-
cillin-Streptomycin (1% v/v), and L-Glutamine (1% v/v) (Sigma-Aldrich,
St. Louis, MO) at 37C and 5% CO2. Before each experiment, cells were
harvested at 70–80% confluency using 0.5% trypsin/EDTA (Sigma-
Aldrich) and washed with culture media. The cell suspension was spun
for 2 min at 460g (2000 rpm) (Allegra X-21; Beckman Coulter, Brea,
CA) and washed with the electroporation buffer containing 0.5 mM
MgCl2, 200 mM sucrose, and 10 mM HEPES (Sigma-Aldrich) (pH 7.4)
(33). The electrical conductivity (CON 6; Oakton Instruments, Vernon
Hills, IL) and osmolality (3D3 Osmometer; Advanced Instruments,
Norwood, MA) of the electroporation buffer were 100 mS/cm and 310
mOsm/kg, respectively (11,33).Electroporation protocol
Approximately 3 106 cells/mL were suspended in the electroporation
buffer containing 100 mM of Fluorescein-Dextran (FD; Life Technologies,
Grand Island, NY) and incubated on ice for 5 min before pulsation. The
physical properties of FD are listed in Table 1 (ex: 494 nm, em: 524 nm).
The electroporation experiments were conducted at room temperature
(20C) under a sterile hood. A volume of 90 mL of cell suspension was
placed into an electroporation cuvette (model No. 89047-206; VWR,
Philadelphia, PA). The cuvette was made from polycarbonate material
with electrodes made from polished aluminum plates. The spacing between
the electrodes was 1 mm. For each data point, one new cuvette is used.
Various combinations of double pulses were applied using a custom-built
electroporator that can deliver calibrated and controlled square pulses
(Fig. 1). The first pulse was programmed at V1 ¼ 100 V (E1 ¼
100,000 V/m) and t1 ¼ 0.001 s in strength and duration at all times, respec-
tively. This pulse has been shown to promote significant permeabilization
with low delivery and high viability trend for different cell and molecule
types (24,25,32,38,47,48,71). Our own experiments using the same field
strength and varying durations also confirm this trend (data not shown).
Ten voltages were used for the second pulse, namely, 10, 20, 25, 30, 35,
40, 50, 60, 80, and 100 V to achieve electric field strengths (E2) between
TABLE 1 List of model parameters
Symbol Definition Value
a Cell radius 7 mm (33)
h Membrane thickness 5 nm
si Intracellular conductivity 0.4 S/m (28,31)
se Extracellular conductivity 0.01 S/m
F Faraday constant 96,485 C/mol
R Universal gas constant 8.314 J/K , mol
T Room temperature 298.15 K
DFD,i Diffusion coefficient of FD
in the cytoplasm
2.90  1011 m2/s (73,74)
DFD,e Diffusion coefficient of FD
in the extracellular solution
9.80  1011 m2/s (75)
zFD Net charge of FD 0.1 (73,74)
[FD]i,o Initial FD concentration
in the cytoplasm
0 M
[FD]e,o Initial FD concentration
in the extracellular solution
100 mM
E1 Applied electric field strength
of first pulse
100,000 V/m
E2 Applied electric field strength
of second pulse
10,000–100,000 V/m
t1 Applied electric field duration
of first pulse
0.001 s
t2 Applied electric field duration
of second pulse
0.01–0.1 s
If reference is not given, value is from this article. FD denotes Fluorescein-
Dextran.
Scaling Relationship and Optimization of Double-Pulse Electroporation 80310,000 and 100,000 V/m. (Note that although we follow the conventional
terminology of HV/LV, for the purpose of parametric study, some of our
second-pulse strengths are approaching that of the first one and are no
longer considered low.) The duration of the second pulse (t2) was varied
between 0.01 and 0.1 s. At postpulsation, the cell suspension was incubated
in complete media for a 15-min period to allow membrane resealing
(37,38,72). To remove free FD, cells were washed twice with phosphate-
buffered saline Mg2þ and Ca2þ for 2 min at 460g (2000 rpm) each
(Sigma-Aldrich). The cells were incubated for another 15 min, then
resuspended in phosphate-buffered saline containing 2 mM of 7-Aminoac-
tinomycin D (7-AAD, 1270.43 Da; Life Technologies), a membrane-imper-FIGURE 1 An exemplary double pulse used in the delivery of
Fluorescein-Dextran into 3T3 mouse fibroblasts. The first pulse was
100,000 V/m in strength and 0.001 s in duration. The second pulse was
30,000 V/m in strength and 0.01 s in duration. The signal was measured
using the software LABVIEW (National Instruments, Austin, TX). To
see this figure in color, go online.meant dye that fluoresces upon binding to DNA (ex: 488 nm, em: 650 nm)
to identify nonviable cells that failed to reseal. Both FD and 7-AAD fluo-
rescence signals were acquired using flow cytometry 2 h after the addition
of 7-AAD. For these experimental conditions and using a simplified model,
the temperature change due to Joule heating was estimated to be 2.5C in
the worse-case scenario.Flow cytometry
A model No. FC500 analyzer flow cytometer (Beckman Coulter) equipped
with CXP ANALYSIS software (Beckman Coulter) was used to perform
measurements of nonelectroporated (control) and electroporated cells.
Forward-scatter (FS) and side-scatter (SS) measurements were used to
distinguish between cells and debris based on cell size and granularity,
respectively. After the cell population was gated based on the FS and SS
measurements of the control condition (nonpulsed cells), 10,000 events
were acquired within the preselected gate for each condition (Fig. 2 a).
Data was collected for each event with long-pass filters at 525- and
675-nm wavelengths to provide a count of FDþ and 7-AADþ cells, respec-
tively. Before each experiment, spectral compensation was performed due
to the overlap of the FD and 7-AAD signals.Flow cytometry data analysis
The cell population was separated from debris using the FS and SS plot as
demonstrated with the circular gate in Fig. 2 a. Subsequently, the gated cell
population was expanded into a scatter plot of 7-AAD intensity (ordinate)FIGURE 2 Exemplary cell analysis with dot plots. (a) Control cells that
were not pulsed. These cells are plotted with respect to forward-scatter
(abscissa) and side-scatter (ordinate). The cell population in panel a is sepa-
rated from debris using a circular gate. (b–d) Abscissa represents the fluo-
rescence signal due to the uptake of Fluorescein-Dextran (FD); the ordinate,
7-Aminoactinomycin D (7-AAD). (Solid lines) Separation of the regions of
uptake and no-uptake of the respective dyes. Cells in panel b are the gated
cells from panel a, which were not pulsed. Cells in panel c received a single
pulse of E1 ¼ 100,000 V/m and t1 ¼ 0.001 s. Cells in panel d received an
additional pulse of E2 ¼ 30,000 V/m and t2 ¼ 0.1 s with no delay with
respect to the first pulse. To see this figure in color, go online.
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804 Sadik et al.versus FD intensity (abscissa) (Fig. 2, b–d). The FD intensity represents the
degree of molecular delivery, whereas 7-AAD represents the presence of a
compromised cell membrane any time between 30 min and 2 h postpulsa-
tion. These 7-AADþ cells were presumed to be nonviable.
The limits for the quadrants in the scatter plots were preselected based on
the compensation analysis discussed in Flow Cytometry. Therefore, cells in
each quadrant represent the following cell populations:
Q1: Dead cells (7-AADþ) that do not contain FD;
Q2: Dead cells (7-AADþ) that contain FD;
Q3: Live Cells (7-AAD) that contain FD; and
Q4: Live cells (7AAD) that do not contain FD.
Fig. 2, b–d, represents dot plots of cells electroporated with different
pulse conditions. Fig. 2 b represents control condition with cells that
were not pulsed. Fig. 2, c and d, represents cells after the application of
a single and a double pulse, respectively. The majority of the dead cells
(7-AADþ) aggregated at a specific fluorescence level for all the experi-
mental conditions, which indicates the saturation of binding sites for
7-AAD within dead cells. The percentage of viable cells (S) was calculated
by normalizing the number of cells without 7-AAD fluorescence (Q3þQ4)
from the pulsed condition with the same number of cells in the nonpulsed
condition.
The vertical line in Fig. 2, b–d, separates cells with FD (Q1 and Q2) and
without FD (Q3 and Q4). The cells from Fig. 2 bwere not pulsed, so, essen-
tially, all the cells were void of FD and fell in Q4. The application of a sin-
gle pulse (E1 ¼ 100,000 V/m, t1 ¼ 0.001 s) shifted the cell population
partially into Q3, indicating FD delivery (Fig. 2 c). The addition of a second
pulse, for example, E2 ¼ 30,000 V/m and t2 ¼ 0.1 s, as shown in Fig. 2 d,
pushed the cell population further into Q3, demonstrating enhanced deliv-
ery. The efficiency of FD delivery was assessed by identifying the median
value of fluorescence intensity (Fig. 3) and determining the increase in in-
tensity relative to a single pulse:
NF ¼ Median ðdouble pulseÞ Median ðsingle pulseÞ
Median ðsingle pulseÞ ;
(1)
where NF denotes normalized fluorescence.Modeling approach
In addition to flow cytometry measurements, we also used numerical
modeling to interpret the trends observed. The model framework combines
an asymptotic Smoluchowski equation (ASE) (71) for membrane permea-
bilization with a Nernst-Planck equation for molecular transport, and the
details are presented in our earlier work (15,29,30). Here we summarize
the key elements.
Pore nucleation and evolution
The ASE model describing the evolution of the pore statistics follows
closely that by Krassowska and Filev (71),Biophysical Journal 106(4) 801–812dN
dt
¼ q1eðVm=VepÞ
2
 
1 N
N0e
q2ðVm=VepÞ2
!
; (2)
drj  
dt
¼ U rj;Vm;G ; j ¼ 1; 2;/; k: (3)
Here N(t,q) is the local pore number density as a function of time, t, and the
polar angle, q (see Fig. 1 in Li and Lin (30)); N0, q1, q2, and Vep are con-
stants. Vm is the transmembrane potential, rj is the evolving pore size,
U is the advection velocity, and G is an effective membrane tension. The
subscript j is the index for the pores in a local area element. According
to this model, pores nucleate at an initial radius, r* ¼ 0.5 nm, and at a
rate described by Eq. 2. They then evolve in size according to Eq. 3 to mini-
mize the total energy of the lipid membrane. Resealing effects are also
captured by the ASE. This permeabilization model is coupled to the full
electrical problem. Further details as well as relevant parameters are found
in Li and Lin (30) and Krassowska and Filev (71), and, for brevity, are not
presented here.
FD transport
We adopt a generalized Nernst-Planck system to simulate species transport.
In the following, we treat the concentration of FD in a continuum, convec-
tive-diffusive framework:
v½FD
vt
¼ V$ ðwFDFzFD½FDVFÞ þ V$ ðDFDV½FDÞ: (4)
Here [FD] denotes the molar concentration of Fluorescein-Dextran,F is the
electric potential, F is the Faraday constant, zFD is the net charge of FD,DFD
is the diffusion coefficient, and wFD is the mechanical mobility (calculated
from DFD using Einstein’s relation, D ¼ wRT, where R is the universal gas
constant, and T is temperature). Equation 4 is solved for both the intra- and
extracellular spaces, and these are coupled on the membrane by continuity
of molar flux density for every species:
Fi;e ¼ Fm; (5)
whereFi;eh n$ ðwFDFzFD½FDVFþ DFDV½FDÞi;e; (6)
DFDðPeFD  ln gÞ ðg1Þ
½FD ½FD expðPeFDÞFmhrp h ln g
e i
ðg expðPeFDÞÞ :
(7)
Here Fi,e values are the flux densities from the intra- and extracellular
spaces, respectively; Fm is the flux density across the membrane; PeFD h
wFDFzFDVm/DFD is an effective Pe´clet number for each species; and g ¼
se/si the extra/intracellular conductivity. The initial intra- and extracellularFIGURE 3 Fluorescein-Dextran fluorescence
signal for three different second-pulse field
strengths at different second-pulse durations. (a)
E2 ¼ 25,000 V/m; (b) E2 ¼ 50,000 V/m; (c)
E2 ¼ 100,000 V/m. The cell populations of each
distribution are obtained from the Q3 quadrant in
Fig. 2, b–d.To see this figure in color, go online.
Scaling Relationship and Optimization of Double-Pulse Electroporation 805FD concentrations are [FD]i,o and [FD]e,o, respectively (Table 1, and see the
literature (72–75)). The permeabilization result affects the species transport
through the pore area density (PAD), rp, in Eq. 7. This quantity is defined by
rpðt; qÞ ¼
XKðt;qÞ
j¼ 1
pr2j =DA; (8)
and is calculated for every area element after the pore statistics. Parameters
specific to this study are listed in Table 1 and others can be found in Li andLin (30).
Numerical implementation
The complete model is solved with a finite-volume, alternative-direction
implicit scheme in an axisymmetric geometry. The axis of symmetry is
aligned with the field direction. A nonuniform spherical grid with higher
resolution around the membrane is adopted to optimize computational effi-
ciency. The numerical convergence is tested with respect to resolution by
increasing the number of grids.RESULTS
In this section, we first present data from flow cytometry for
all experimental conditions, as well as results from the
modeling simulation. A comparison between the two fol-
lows. A scaling-relationship-based optimization approach
is presented last.FIGURE 4 (a and b) The normalized fluorescence (NF) of intracellular
Fluorescein-Dextran as a result of double-pulse electroporation. (Symbols)
Experimental data; (curves) least-square fitting. For all cases, the first pulse
was always E1 ¼ 100,000 V/m and t1 ¼ 0.001s. To see this figure in color,
go online.Experimental results
The effects of the second-pulse duration (t2) and strength
(E2) on the delivery of FD are examined in Fig. 4. Each
data point is based on a population of 10,000 cells and is
obtained with the analytical method outlined in Flow
Cytometry Data Analysis. The normalized fluorescence
(NF) is calculated according to Eq. 1. Fig. 4 a demonstrates
that delivery increases linearly with t2. Fig. 4 b shows that
NF exhibits three regimes with respect to E2 for all t2 values.
In the first, NF increases slowly until E2 reaches 35,000
V/m, which is followed by a rapid rise between E2 ¼
40,000 V/m and E2 ¼ 60,000 V/m. A plateau is reached
for E2 > 60,000 V/m. To construct a global picture of the
system behavior, we use least-square fitting to further pro-
cess the data. (This method is also practiced below for
viability.) The data from Fig. 4 a for each constant value
of E2 are first fitted with lines,
NF ¼ aðE2Þ  t2; (9)
where a is the slope of each individual line (solid lines in
Fig. 4 a), which corresponds to the delivery rate per unit
time. Similarly, in Fig. 4 b, the solid lines represent
sigmoidal fittings for constant t2 values and for brevity,
the specific forms are not given here. The slope a as ob-
tained from Eq. 9 is plotted as a function of E2 in Fig. 5.
The error bars represent the 95% confidence interval of
the linear curve fits in Fig. 4 a. The sigmoidal behavior is
consistent with the individual curves in Fig. 4 b. The dashed
lines represent the fittingaðE2Þ ¼ amax
1þ exp

E2;c  E2
b
; (10)
where amax, E2,c, and b are fitting constants, and the values
can be found in Table 2. Considering Eqs. 10 and 11
together, the entire data set in Fig. 4 a can be approximated
by the following relation:
NF ¼ amax
1þ exp

E2;c  E2
b
  t2: (11)
This construction summarizes the whole data trend for
delivery.
The effects of the second-pulse parameters on viability
(S) are presented in Fig. 6. Cells exposed to only a single
pulse, the first pulse only, demonstrated the highest S at
~97.3%. Similar results were observed by other authors
(32,38). For instance, in Puc et al. (32) (in Fig. 2, c
and d), ~90% of cells were permeabilized without affectingBiophysical Journal 106(4) 801–812
FIGURE 5 The delivery rate per unit time (a, circles) as a function of E2.
The value a is extracted from Fig. 4 a by calculating the slopes of the lin-
early fitted lines (Eq. 10), and the error bars represent the 95% confidence
interval of the fitting. The correlation between a and E2 can be further
approximated by a least-square sigmoidal fitting (dashed). The coefficient
of determination is R2 ¼ 0.97.
FIGURE 6 The percentage of viable cells after double-pulse electropora-
tion. (Symbols) Experimental data; (curves) least-square fitting. For all
cases, the first pulse was always E1 ¼ 100,000 V/m and t1 ¼ 0.001 s. To
see this figure in color, go online.
806 Sadik et al.the overall viability at 1 ms and 1 kV/cm. Viability
decreased linearly with increasing t2 (Fig. 6 a) and quadrat-
ically with increasing E2 (Fig. 6 b). The solid lines are linear
and quadratic fitting for constant E2 and t2, respectively.
Collectively, the dependence of S on t2 and E2 suggests
that viability is dependent on the electrical energy (E2
2t2).
Indeed, as shown in Fig. 7, the relationship between S and
E2
2t2 is well captured by a straight line with a high coeffi-
cient of determination (R2 ¼ 0.946),
S ð%Þ ¼ S0  hE22t2; (12)
where S0 and h represent fitting parameters; their values can
be found in Table 2.
The scaling relationships (Eqs. 11 and 12 are the basis for
an optimization method that will be discussed in the subsec-
tion Optimization. Below, we present modeling results to
provide basic insights for interpretation of the data trend.Computational results
In this section, we use the modeling framework outlined in
Modeling Approach to simulate both membrane permeabi-
lization and FD transport, such as to correlate with the
experimental observations.TABLE 2 Curve-fitting constants for Eqs. 10–15
Symbol Value
af,max 1310 a.u.
E2,c 50,000 V/m
b 5156 V/m
So 97.3%
h 1.49  107 m2%/V2s
Biophysical Journal 106(4) 801–812Fig. 8 shows exemplary results on membrane permeabili-
zation. Fig. 8 a shows the evolution of the PAD (rp) for E2¼
30,000 V/m, and t2 ¼ 0.001 s. Here q ¼ 0 is facing theFIGURE 7 Scaling law of viability with respect to the electrical energy
(E2
2t2). (Symbols) Experimental data; (dashed curve) least-square fitting
given by Eq. 12. Viability decreases linearly with increasing electrical
energy. To see this figure in color, go online.
FIGURE 8 (a) Polar distribution of the pore area density (PAD). For this
case, E2¼ 30,000 V/m, t2¼ 0.001 s, q¼ 0 for the cathode-facing pole, from
which side most of the negatively charged FD molecules enter. (b) The evo-
lution of TPA as a function of time. For all cases, t2 ¼ 0.001 s. To see this
figure in color, go online.
Scaling Relationship and Optimization of Double-Pulse Electroporation 807cathode pole, and clearly after the first pulse ceases at t1 ¼
0.001 s, the PAD on both cathode- and anode-facing caps
drops to a lower level. This level is strongly correlated
with the value of E2. To characterize the degree of permea-
bilization, we defined a new quantity, namely, total permea-
bilized area (TPA),
TPA ¼
Z2p
0
df
Zp=2
0
rpdq; (13)
where f is the azimuthal coordinate. Upon considering thatFIGURE 9 (a) Simulated results of delivery of total FD (TFD) and (b)
delivery rate of Dextran (asim) plotted as a function of t2 and E2. To see
this figure in color, go online.the negatively charged FD mainly enters against the direc-
tion of the applied field, note the integration with respect
to q is from 0 to p/2 on the cathode-facing hemisphere
only. The evolution of the TPA as a function of time for
different E2 values is shown in Fig. 8 b. Upon the application
of the second pulse, the TPA appears to adjust rapidly to a
new equilibrium value, which is maintained until the end
of the pulse. Common to the ASE model, the pores shrinkto a value close to r* ¼ 0.5 nm almost immediately postpul-
sation (24,30). The resulting values for the TPA are ~104
mm2 for this postpulsation stage. The trends are similar for
other t2 values that, for the sake of brevity, are not shown
here.
Fig. 9 shows the total FD (denoted as TFD) delivered into
the single simulated cell for all E2 and t2 values studied
experimentally. In agreement with the experimental data,
the TFD correlates linearly with t2. Similar to the treatment
of the experimental data, we fit TFD as a function of t2 in
Fig. 9 a with lines, and the resulting slope (denoted by
asim) is plotted as a function of E2 in Fig. 9 b. Consistent
with our experimental work, we observed no significant
delivery (per unit time) until E2 reaches a threshold value.
However, note that the threshold value for E2 is ~25,000
and 50,000 V/m from the experimental and computational
results, respectively. Above this value, asim exhibited a
strong and almost linear correlation with E2 (Fig. 9 b). In
comparison, we also show the behavior of the TPA in the
same figure. For all E2 values, the value of the TPA is taken
at t ¼ 0.0015 s, at which time an equilibrium has been estab-
lished for the second pulse. Theoretically, this equilibriumBiophysical Journal 106(4) 801–812
808 Sadik et al.value depends only on the strength of the second pulse, and
not on the strength or the duration of the first one. The two
curves in Fig. 9 b share a similar trend.Comparison between experimental and
computational data
In this study, the linear behavior of delivery with respect to
t2 in both the experimental data and the simulations alludes
to the dominant role of electrophoretic transport for mole-
cules larger than 4 kDa (25). An exemplary animation of
the simulated FD delivery process with a double pulse is
included in Movie S1 in the Supporting Material. Although
FD does enter the cell via diffusion during and after the
pulse application, the contribution is negligibly small per
the simulated results. In general, electrophoresis is a fast
and active mechanism when compared with diffusion or
endocytosis, and is speculated to be the main viable mech-
anism for molecules >4 kDa (25,30,76).
When compared with the experimental data, the simula-
tion notably captured a critical field above which the deliv-
ery with the second pulse becomes effective, although the
specific values are different (25,000 and 50,000 V/m,
respectively). In this simulation, this critical phenomenon
is mediated by that in the pore dynamics. According to
the model, when the transmembrane potential is below a
threshold value of 0.44 V, pores on the membrane shrink
to an equilibrium size of ~1 nm, leading to a weak degree
of permeabilization. Theoretically, this threshold value
depends only on the energy landscape of the pores, or equiv-
alently, the right-hand side of Eq. 3, and not on the details of
the first pulse. Once the threshold is reached, pores expand
to a new equilibrium size of ~10 nm. This expansion signif-
icantly increases the membrane permeability (reflected in
the TPA in Fig. 9), which also allows for appreciable FD
electrotransfer. This behavior in pore dynamics is well illus-
trated by, e.g., Fig. 1 in Neumann (77) (and Fig. 7 in M. Yu
and H. Lin, unpublished). However, the discrepancy indi-
cates a necessity for model improvement. Using a simple
estimate relating applied field strength and transmembrane
potential, the critical value for the latter is estimated to be
~0.22 V for E2 ¼ 25,000 V/m (78). This value can beBiophysical Journal 106(4) 801–812used as a constraint to help revise the energy landscape in
the ASE theory.
The simulation also does not capture the plateau in Fig. 5.
The cause for this behavior is unknown, and we speculate
that it is due to the higher cell-death rate at a field strength
approaching 100,000 V/m. During the pulse, a higher field-
strength always leads, if only briefly, to higher delivery.
However, because FD molecules do not bind within the
cell, they may eventually diffuse out of the cell if the mem-
brane remains open for an extended period of time, e.g., in
case of cell death. The enhanced delivery therefore does not
manifest itself in the data we collected exclusively from Q3
(i.e., live cells only). This effect is not captured by the trans-
port model, which does not include viability predictions.Optimization
The above studies helped establish the scaling relationships
of both delivery and viability with respect to the pulsing
parameters. There indeed exists a regime where transport
via the second pulse is the most effective. However, to
develop an optimization approach, delivery and viability
need to be considered in conjunction with each other. The
availability of Eqs. 11 and 12 allows us to construct a direct
relation between them. We start by specifying a desired
viability, e.g., S ¼ 70%. Equation 12 allows us to identify
the pulse length t2 given the field strength E2:
t2 ¼ S S0
hE22
: (14)
Next, this equation is substituted into Eq. 11 to obtainNF ¼ amax
1þ exp

E2;c  E2
b
  ðS S0Þ
hsE
2
2
: (15)
This relation expresses delivery (NF) as a function of E2 and
S, and is plotted in Fig. 10. For each curve, the viability is
kept constant. Therefore, by varying E2, an optimal field
strength can be identified without sacrificing viability.
This optimal strength is exactly reached when each
constant-viability contour reaches its maximum, which isFIGURE 10 NF as a function of E2 and S (Eq.
15). (a) The curves can be regarded as constant-
viability contours in the phase space of E2 and
NF. A maximum value of NF is reached at E2 ¼
58,000 V/m for all S values. (b) The maximum
value of NF for each value of S in panel a. An
inverse linear correlation is observed. To see this
figure in color, go online.
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maximum achievable NF decreases linearly with viability,
as shown in Fig. 10 b. This result is not surprising, because
both NF and S depend linearly on t2.
Fig. 10 is the main result of this work, which suggests that
if the scaling relationships of both delivery and viability
with respect to the pulsing parameters can be established,
then optimization can systematically pursued. In discus-
sions below, we argue that this approach can be generalized
to other cell and other molecule types (32).DISCUSSION
In our experiments, we used 7-AAD, a molecule that is
approximately twice the molecular weight of propidium io-
dide, to examine membrane integrity and cell viability (79).
We believe that this method is a suitable assay for short-term
cell death/viability. The dye was added ~30-min postpulsa-
tion, and was present in the cell suspension for an average of
2 h until flow cytometry data acquisition (37,38,72). From
the literature, the time constant for membrane resealing
ranges from seconds to minutes (7,12,13,80,81). Therefore,
a cell that is permeant between 30- and 150-min postpulsa-
tion will likely remain so permanently (38). In addition, the
extended opening of the membrane will significantly perturb
the homeostasis of the cell, and will most likely result in
necrosis or apoptosis (34,35,82–84). On the other hand,
cells that sealed at 30 min may also be at risk of cell death
at long-term due to biochemical processes such as nuclear
DNA fragmentation, membrane protein denaturation, etc.
(38,84). Therefore, the short-term cell-death rate can be
regarded as a lower bound for the long-term counterpart
(38,83). The relationship between short- and long-term
cell viability and membrane permeabilization is a complex
one. A full understanding and quantification has yet to be
established, which is the scope of future work (37,38,84).
We remark that a similar analysis (using propidium iodide
10-min postpulsation) has been performed by Canatella et al.
(37). The study established a qualitative correlation between
short-term cell death and the electrical energy. However, the
data thereinwas scattered, and did not exhibit quantitatively a
linear correlation aswe have presented in this work.We spec-
ulate that the difference is caused by the use of decaying
instead of square pulses by this earlier work.
In this work, we have selectively investigated the delivery
of a single molecular type into a single cell type using HV/
LV pulses. Once the target molecule’s size and charge, cell
type, and pulsing parameters (e.g., HV field strength, dura-
tion, and the delay between pulses) change, the scaling rela-
tionships may vary accordingly. Nonetheless, we speculate
that the data trends observed here assume some generality:
 The sigmoidal dependence on pulse strength for various
pulse types corroborates with earlier work, for both small
(32,39,85) and large molecules (39,42,48,68), and fordifferent cell types (72). The consistency is not surprising,
and attests to the general presence of the lower and upper
bounds on delivery as we have previously explained.
 As long as delivery and viability scale differently with the
pulsing parameters, an optimal field strength is always
identifiable (32,39,42,51,72). For the specific case, pre-
sented in Fig. 10, the equiviability contours exhibit a
characteristic dome-shape. Curve ascension is attributed
to the fact that delivery increases more rapidly than the
drop in viability with respect to the field strength; a
converse situation leads to the descent. With a change
in cell/molecule type, we expect the quantitative details
of the curves to vary, but we speculate that the character-
istic dome-shape persists.
This work leads to the proposal that similar experiments
need to be repeated for a matrix of cell/molecule combina-
tions. The electric field strength and duration of the HV can
be tailored with respect to the target molecule to enhance
overall performance (see, e.g., Puc et al. (32)). These exper-
iments will each provide answers to the three questions
outlined in the Introduction. In addition, further quests can
be pursued. For example, Fig. 9 b provides an estimate for
the critical TMP threshold for effective delivery, which we
construe as the threshold for pore expansion. Finding how
this value varies with cell type can help build up connections
between membrane composition and mechanics. Further-
more, the strong regularity in the relationship between
viability and the electrical energy encourages us to further
explore similar trends in other cell types. This regularity
also suggests that a nonspecific, physical mechanism
may be dictating short-term viability, at postpulsation.
These efforts help move electroporation-mediated molecu-
lar delivery toward a quantitative science.CONCLUSION
In this work, we performed electroporation experiments to
diagnose the effects of HV/LV pulses on delivery and cell
viability. The electric pulse was split into two stages without
a delay in between: a short, strong pulse to permeabilize the
membrane with minimal cell damage, and a second pulse
with long duration to extend the electrophoretic transport.
The delivery of FD into 3T3 mouse fibroblasts was analyzed
with flow cytometry. The main findings, in response to the
three questions put forward in the Introduction, are:
1. The LV is much more effective than the HV alone in
mediating molecular delivery. The delivery scales line-
arly with the length of the LV, and exhibits a sigmoidal
behavior with respect to its strength. Indeed, according
to this behavior, delivery is the most effective for moder-
ate-amplitude electric fields.
2. Viability exhibits a convincing linear correlation with the
electrical energy. The strong regularity in the data trend
is a main contribution of this work.Biophysical Journal 106(4) 801–812
810 Sadik et al.3. The different yet well-defined scaling relationships of
delivery and viability on the pulsing parameters ensure
that optimal field strength can be identified to achieve
maximum delivery without compromising viability.
We have also employed a whole-cell level model to pre-
dict permeabilization and delivery. A direct comparison
between the experimental and numerical results elucidates
underlying mechanisms governing the system behavior.
The model prediction corroborates the linearity between
delivery and the second-pulse duration. The existence of a
threshold TMP value for effective delivery with the second
pulse is related to a sudden expansion in the equilibrium
pore size at that critical point. Although the data trends in
this study are observed for a single cell/molecule combina-
tion, we speculate that the qualitative behavior persist for
other configurations. Together, our efforts establish a route
for protocol optimization: Targeted optimization is only
possible when both the scaling behavior for delivery and
viability are quantified, and can be predicted. This work
is, to our knowledge, the first step toward moving elec-
troporation-mediated molecular delivery to a predictable
technique.SUPPORTING MATERIAL
One movie is available at http://www.biophysj.org/biophysj/supplemental/
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